In addition to generating polymeric products from human fibrinogen, human erythrocyte transglutaminase (protein-glutamine:amine y-glutamyltransferase, EC 2.3.2.13) was shown to catalyze the intramolecular reaction of crosslinking two of the constituent chains within monomeric fibrinogen itself. This internally fused protein derivative contains appreciable amounts of the N6-(y-glutamyl)lysine bridge peptide and displays the Aa-y hybrid chain pattern of crosslinking, characteristic for the actions of tissue transglutaminases on fibrinogen. Diagnostic analysis in pathological situations, where such enzymes might have escaped from cells into the plasma environment, should include a search for the internally crosslinked soluble fibrinogen monomer.It is known that human fibrinogen, upon reaction with a tissue transglutaminase (protein-glutamine:amine y-glutamyltransferase, EC 2.3.2.13) from human erythrocytes or from guinea pig liver, forms high molecular weight multimeric products by a program of polymerization different from that seen with coagulation factor XIIIa (1, 2). Factor XIIIa promotes first y-to-y and then Aa-to-Aa chain homologous crosslinking (3), whereas Aacy type of hybrid crosslinking is the unique feature of the action of transglutaminase on fibrinogen. The question arises (1) whether these unusual crosslinks, apart from participating in the intermolecular process of polymerization, might also be introduced intramolecularly between the constituent Aa and r chains of monomeric fibrinogen itself. This issue became even more pertinent when we found that, even after extended exposure of fibrinogen to transglutaminase, a sizeable portion of the protein remained in the unpolymerized Mr 340,000 form. The present report shows that the monomeric species of fibrinogen, reisolated from the mixture after reaction with erythrocyte transglutaminase, contains significant amounts of the N'-(y-glutamyl)lysine bridge peptide and shows the characteristic Aay hybrid chain pattern of crosslinking (1).
MATERIALS AND METHODSThe contents of one vial of human fibrinogen (40 mg, IMCO, American Diagnostica, Greenwich, CT) were dissolved in 3 ml of buffer (50 mM Tris HCl, pH 7.5/150 mM NaCl/1 mM EDTA) and were dialyzed against 4 liters of the same buffer for 16 hr at 4'C. The concentration of fibrinogen (11.6 mg/ml) was estimated using A 1% = 15.1 (4). Human erythrocyte transglutaminase was purified by David Schilling to apparent SDS/PAGE homogeneity based on a published procedure (5). Concentration of the erythrocyte enzyme [1.7 mg/ml of 20 mM imidazole HCI, pH 6/1 mM EDTA/1 mM dithiothreitol/0.35 M KCI/10 units of Trasylol per ml/5% (vol/vol) glycerol] was estimated by using the BCA assay kit (Pierce) according to the manufacturer's instructions. Erythrocyte transglutaminase was stored at -80'C.Crosslinking of fibrinogen was typically carried out at 370C for 1 hr in reaction mixtures of about 24 ml containing approximately 2.3 ,M fibrinogen, 0.1 M NaCl, 50 mM Tris HCI (pH 7.5), and ca. 0.3 AM erythrocyte transglutam...